2. Academic Validation
  3. HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth

HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth

  • J Med Chem. 2026 Feb 12;69(3):2025-2040. doi: 10.1021/acs.jmedchem.5c01704.
Jacques Huck 1,  Caroline Joannesse 2,  Adeline Palisse 2,  Sébastien Richard 1,  Olivier Picolet 1,  Thi Thu Trang Mai 1,  Vanessa Quenehen 1,  Elena Borregán-Ochando 2,  Pascal Savy 3,  Oscar Mammoliti 2,  Juan-Miguel Jimenez 2,  Romain Gosmini 1,  Filip Beirinckx 2,  Annelies Iwens 2,  Melanie Chypre 2,  Kim De Rijck 2,  Nele Vandervoort 2,  Philippe Clément-Lacroix 1,  Carole Delachaume 1,  Cécile Belleville 1,  Line Oste 2,  Monica Borgonovi 1,  Emanuelle Wakselman 1,  Mia Jans 2,  Josee Hue-Perron 1,  Reginald Brys 2,  Laurent Saniere 1,  Martin Andrews 2
Affiliations

Affiliations

  • 1 Galapagos SASU, 102 Avenue Gaston Roussel, Romainville 93230, France.
  • 2 Galapagos NV, Generaal De Wittelaan L11 A3, Mechelen 2800, Belgium.
  • 3 Charles River, 8/9 Spire Green Centre, Harlow, Essex, CM19 5TR, United Kingdom.
PMID: 41557952 DOI: 10.1021/acs.jmedchem.5c01704
Abstract

Chronic hepatitis B virus (HBV) Infection remains a major global health burden. Despite the widespread availability of effective prophylactic vaccines, millions of people are at risk for complications of chronic HBV Infection. Nucleoside polymerase inhibitors are highly effective at suppressing the production of infectious viral particles and decreasing the risk of cirrhosis; however, viral clearance remains very rare, which means that treatment is often lifelong. Alternative therapeutic agents with a new mode of action giving sustained activity of treatment are needed. We report a new thiochromeno[4,3-b]pyridine-based scaffold, which targets hepatitis B surface antigen (HBsAg). Suppression of HBsAg in patients is currently thought to be critical for immune reactivation, allowing durable response in patients. We describe the medicinal chemistry approach taken to advance the series, including the in vitro neurite outgrowth assay used to evaluate the risk of neurotoxicity seen in Other clinical candidates.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-181348
    HBsAg Inhibitor
    HBV